Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGK1 | P00558 | 1/20 | 0.53 |
| ▸ | PGK2 | P07205 | 1/20 | 0.53 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CETP | P11597 | 3/20 | 0.41 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.41 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.41 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6044969 | 0.83 | PGK1 (0.60) | PGK1PGK2 | |
| SCHEMBL6044962 | 0.80 | PGK1 (0.35) | PGK1PGK2CETP | |
| SCHEMBL6044960 | 0.80 | PGK1 (0.35) | PGK1PGK2CETP | |
| SCHEMBL6044956 | 0.80 | PGK1 (0.35) | PGK1PGK2CETP | |
| SCHEMBL4544102 | 0.78 | PGK1 (0.62) | PGK1PGK2KCNH2 | |
| SCHEMBL17489025 | 0.77 | PGK1 (0.53) | PGK1PGK2CYP3A4 | |
| SCHEMBL1246418 | 0.77 | CETP (0.58) | CYP3A4CETP | |
| SCHEMBL6045059 | 0.74 | CYP3A4 (0.48) | PGK1PGK2CYP3A4CETPLPAR1 | |
| SCHEMBL3234996 | 0.72 | ESR1 (0.46) | CYP3A4CETPLPAR1LPAR3LPAR2 | |
| SCHEMBL11297495 | 0.71 | CETP (0.63) | CETPLPAR1LPAR3LPAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060210479-A1 | Targeting chelants and chelates | DOW GLOBAL TECHNOLOGIES INC. (US) | 2006-09-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060210479-A1 | Targeting chelants and chelates | CLTC, CALCOCO2, TFRC | PGK1 2785/4885PGK2 2466/4885KCNH2 3715/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.